Potential interaction between warfarin and fluvastatin

被引:37
作者
Trilli, LE [1 ]
Kelley, CL [1 ]
Aspinall, SL [1 ]
Kroner, BA [1 ]
机构
[1] UNIV PITTSBURGH,SCH PHARM,DEPT PHARM & THERAPEUT,PITTSBURGH,PA 15261
关键词
D O I
10.1177/106002809603001207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To report three cases of a suspected interaction between warfarin and fluvastatin. CASE SUMMARIES: Three patients receiving stable warfarin dosages with therapeutic international normalized ratios (INRs) exhibited increased INRs when fluvastatin was added to their maintenance regimens. While none of the patients experienced a bleeding episode, they did require a reduction in their weekly warfarin dosage to achieve an appropriate level of anticoagulation. DISCUSSION: Reports of an interaction between warfarin and lovastatin have been described previously; however, to our knowledge, this is the first published report of a possible interaction between warfarin and fluvastatin. These cases were chosen because other factors that could potentially increase the INR were ruled out as significant contributors. CONCLUSIONS: The exact mechanism for the potential interaction between warfarin and fluvastatin is unknown. Until more is known, it is advisable to monitor patients more frequently when fluvastatin is initiated, discontinued, or adjusted in patients taking warfarin.
引用
收藏
页码:1399 / 1402
页数:4
相关论文
共 13 条
[1]   LOVASTATIN - WARFARIN INTERACTION [J].
AHMAD, S .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (11) :2407-2407
[2]   CATALYTIC ACTIVITIES OF HUMAN LIVER CYTOCHROME-P-450-IIIA4 EXPRESSED IN SACCHAROMYCES-CEREVISIAE [J].
BRIAN, WR ;
SARI, MA ;
IWASAKI, M ;
SHIMADA, T ;
KAMINSKY, LS ;
GUENGERICH, FP .
BIOCHEMISTRY, 1990, 29 (51) :11280-11292
[3]   INTERACTIONS WITH HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE INHIBITORS [J].
GARNETT, WR .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (15) :1639-1645
[4]  
HIRSH J, 1991, NEW ENGL J MED, V324, P1865
[5]  
Hoffman H S, 1992, Conn Med, V56, P107
[6]  
JUNGNICKEL PW, 1992, CLIN PHARMACY, V11, P677
[7]  
PAN HY, 1990, TREATMENT SEVERE HYP, V2, P66
[8]  
*SAND PHARM CORP, 1993, PACK INS LESC FLUV S
[9]   IN-VIVO INHIBITION PROFILE OF CYTOCHROME P450(TB) (CYP2C9) BY (+/-)-FLUVASTATIN [J].
TRANSON, C ;
LEEMANN, T ;
VOGT, N ;
DAYER, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (04) :412-417
[10]   BINDING OF FLUVASTATIN TO BLOOD-CELLS AND PLASMA-PROTEINS [J].
TSE, FLS ;
NICKERSON, DF ;
YARDLEY, WS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (09) :942-947